Axsome Therapeutics
Biopharma developing prescription medicines for psychiatric and neurologic brain disorders such as depression and migraine
Highlights
- GrowingRevenue +66% YoY (FY2025)
Recent signals
What changed at Axsome Therapeutics in the last 6 months, newest first. Each line links to its public source.
- 10 Nov 2026 Revenue jump · Revenue €339.4M → €561.9M (+66%) in FY2025 sec.gov
- 22 Oct 2026 Leadership hire · Hiring Regional Business Director, Long Term Care (Great Plains) (St. Louis) job-boards.greenhouse.io
- 16 Oct 2026 Leadership hire · Hiring Associate Director, IT Business Solutions (New York) job-boards.greenhouse.io
- 14 Oct 2026 Leadership hire · Hiring Director, IT Operations (New York) job-boards.greenhouse.io
About Axsome Therapeutics
Axsome Therapeutics, Inc. is a biopharmaceutical company developing therapies for central nervous system conditions. Its approved medicines are AUVELITY (dextromethorphan-bupropion) for Alzheimer's disease agitation, Sunosi (solriamfetol) and SYMBRAVO (meloxicam and rizatriptan). Its focus areas include depression, schizophrenia, ADHD, migraine, sleep disorders, epilepsy and fibromyalgia.
The company sells its approved medicines to patients and to the physicians who treat them, and its field sales teams cover regions across the United States. The company reports 3 approved medicines, 6 candidates in development and 10 pipeline programs.
Axsome was founded in January 2012 and is led by founder and CEO Herriot Tabuteau, MD. Current job postings include specialty and key account sales roles across the United States, along with clinical research, medical affairs, marketing and investor relations positions, many based in New York.
Product: Prescription medicines AUVELITY, Sunosi and SYMBRAVO, plus candidates in clinical development for CNS conditions.
Jobs at Axsome Therapeutics
Open roles at Axsome Therapeutics in the Americas (102)
United States 102. From Axsome Therapeutics's careers page or applicant tracking system; each role links to the employer.
- Specialty Account Manager, Symbravo (Lexington, KY) · Lexington, United States
- Key Account Manager, Long Term Care (Great Lakes Region) · Indianapolis, United States
- Specialty Account Manager, Long Term Care (New Orleans, LA) · New Orleans, United States
- Specialty Account Manager, Long Term Care (Nashville, TN) · Nashville, United States
- Specialty Account Manager, Long Term Care (Memphis, TN) · Memphis, United States
- Specialty Account Manager, Long Term Care (Little Rock, AR) · Little Rock, United States
- Specialty Account Manager, Long Term Care (Jackson, MS) · Jackson, United States
- Medical Writer/Senior Medical Writer (Medical Affairs) · New York, United States
- Manager/Senior Manager, Market Research · New York, United States
- Manager, Sales Training and Development · New York, United States
- Specialty Account Manager, Long Term Care (Peoria, IL) · Peoria, United States
- Specialty Account Manager, Long Term Care (Omaha, NE) · Omaha, United States
Newest 12 of 102.
Leadership
- Herriot Tabuteau · Chief Executive OfficerSource: company website
- Ari Maizel · Chief Commercial OfficerSource: company website
- Mark Jacobson · Chief Operating OfficerSource: company website
- Nick Pizzie · Chief Financial OfficerSource: company website
More biotech & pharma companies
Beeline Medicines
Clinical-stage biotech developing precision therapies for autoimmune and inflammatory diseases, led by a lupus candidateNew on EvolcSalary transparentBeigene
Develops oncology medicines and runs clinical trials for cancer patients and healthcare providers worldwideNew on EvolcRemote-friendlySalary transparentBluerocktx
Develops cell therapies for patients with degenerative diseases, including neurology and ophthalmology conditionsNew on EvolcBridgeBio Pharma
Develops drugs for rare genetic conditions, including ATTR amyloidosis, achondroplasia and muscular dystrophyGrowingRemote-friendlyBristolmyerssquibb
Biopharmaceutical company developing prescription medicines for serious diseases in oncology, hematology and neuroscienceNew on EvolcCorcept Therapeutics
Develops cortisol-modulating medicines for patients with serious diseases
Website technologies
Tools and platforms detected on this company’s website, grouped by purpose. Dates record when Evolc observed them.
Analytics
- Google Tag ManagerMedium confidence
- First detected
- Last detected
- Last checked
Detection evidence
- Integration code on pageinline script loader
Content delivery
- CloudflareHigh confidence
- First detected
- Last detected
- Last checked
Detection evidence
- Response headerserver
- Response headerserver
- Response headerserver
Content management
- WebflowHigh confidence
- First detected
- Last detected
- Last checked
Detection evidence
- Website resourcedeclared script/iframe or software asset
- WordPressHigh confidence
- First detected
- Last detected
- Last checked
Detection evidence
- Website resourcedeclared script/iframe or software asset
Forms
- Google reCAPTCHAHigh confidence
- First detected
- Last detected
- Last checked
Detection evidence
- Website resourcedeclared script/iframe or software asset
Frontend frameworks
- jQueryHigh confidence
- First detected
- Last detected
- Last checked
Detection evidence
- Website resourcedeclared script/iframe or software asset
Hosting
- AWSHigh confidence
- First detected
- Last detected
- Last checked
Detection evidence
- Website resourcedeclared script/iframe or software asset
Privacy & consent
- OneTrustMedium confidence
- First detected
- Last detected
- Last checked
Detection evidence
- Integration code on pageinline script loader
Website detection does not establish a paid subscription or company-wide use. Tools loaded after consent or sign-in may be missed. “No longer observed” does not prove the company stopped using a tool.